Patent details

EP2380903 Title: Differential in tumour gene products and use of same

Basic Information

Publication number:
EP2380903
PCT Application Number:
Type:
European Patent Granted for LU
Legal Status:
In force
Application number:
EP110020179
PCT Publication Number:
First applicant's nationality:
Translation Language:
EPO Publication Language:
German
English Title of Invention:
Differential in tumour gene products and use of same
French Title of Invention:
Produits géniques d'expression différentielle dans les tumeurs et leur utilisation
German Title of Invention:
Differentiell in Tumoren exprimierte Genprodukte und deren Verwendung
SPC Number:

Dates

Filing date:
18/05/2005
Grant date:
05/04/2017
EP Publication Date:
26/10/2011
PCT Publication Date:
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
05/04/2017
EP B1 Publication Date:
05/04/2017
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
Expiration date:
18/05/2025
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
03/03/2020
 
 

Name:
Astellas Pharma Inc.
Address:
5-1, Nihonbashi-Honcho 2-Chome, Chuo-ku, Tokyo 103-8411, Japan (JP)

History of Owners

From:
23/06/2017
To:
03/03/2020

Name:
Ganymed Pharmaceuticals GmbH
Address:
An der Goldgrube 12, 55131 Mainz, Germany (DE)

From:
05/04/2017
To:
23/06/2017

Name:
Ganymed Pharmaceuticals AG
Address:
An der Goldgrube 12, 55131 Mainz, Germany (DE)

Agent

Name:
Office FREYLINGER S.A.
From:
31/05/2017
Address:
PO Box 48, 8001, STRASSEN, Luxembourg (LU)
To:

Inventor

1

Name:
Türeci, Özlem
Address:
Germany (DE)

2

Name:
Sahin, Ugur
Address:
Germany (DE)

3

Name:
Koslowski, Michael
Address:
Germany (DE)

4

Name:
Fritz, Stefan
Address:
Germany (DE)

5

Name:
Geppert, Harald-Gerhard
Address:
Germany (DE)

Priority

Priority Number:
102004024617
Priority Date:
18/05/2004
Priority Country:
Germany (DE)

Classification

IPC classification:
A61K 39/395; A61P 35/00; C07K 14/47; C07K 16/30;

Publication

Bulletin

Bulletin Heading:
CO
Bulletin edition number:
2020/05
Publication date:
09/04/2020
Description:
Section M : Transfers of property (Art. 53 of the law), change of name and/or address

European Patent Bulletin

1

Issue number:
201714
Publication date:
05/04/2017
Description:
Grant (B1)

2

Issue number:
201730
Publication date:
26/07/2017
Description:
Transfer of Rights

Deed

Change of owner(s)

Change Kind/ Decision Type:
Change of ownership
Deed Number:
RC20200000067A
Date Registered:
03/03/2020
Licence Effective Date:
Licence Expiration Date:
Scope of Licence:
Deed Filer:
OFFICE FREYLINGER S.A.
Journal Edition Number:
Text:
Country Code:
Updated Licence Number:
Terminated Licence Number:

Added Owner(s)

Name:
Astellas Pharma Inc.
Address:
5-1, Nihonbashi-Honcho 2-Chome, Chuo-ku, Tokyo 103-8411, Japan (JP)

Removed Pledgee

Name:
Address:

Annual Fees

Annual Fee Due Date:
Annual Fee Number:
Expected Payer:
Last Annual Fee Payment Date:
27/05/2024
Last Annual Fee Paid Number:
20
Last Annual Fee Paid Amount:
300 Euro
Payer:
Computer Packages INC
Filing date Document type Number of pages
09/06/2017 Outgoing Correspondence 1
17/03/2020 Outgoing Correspondence 1
03/03/2020 Request For Change 14
31/05/2017 Power Of Attorney 1